These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3095125)
1. Leukemic cells arise from cloned cytotoxic lymphocytes during cell culture. Simon MM; Ali S; Tewari R; Simon HG; Müller-Hermelink HK; Epplen JT Eur J Immunol; 1986 Oct; 16(10):1269-76. PubMed ID: 3095125 [TBL] [Abstract][Full Text] [Related]
2. Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity. Weltzien HU; Kempkes B; Jankovic DL; Eichmann K Eur J Immunol; 1986 Jun; 16(6):631-9. PubMed ID: 2424767 [TBL] [Abstract][Full Text] [Related]
3. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
4. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells. Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649 [TBL] [Abstract][Full Text] [Related]
5. Immunoregulation by mouse T cell clones. III. Cloned H-Y-specific cytotoxic T cells secrete a soluble mediator(s) that inhibits cytotoxic responses by acting on both Lyt-2- and L3T4- lymphocytes. Simon MM; Nerz G; Prester M; Moll H Eur J Immunol; 1985 Aug; 15(8):773-83. PubMed ID: 2411568 [TBL] [Abstract][Full Text] [Related]
6. Characterization of cloned cytotoxic lymphocytes with NK-like activity. Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907 [TBL] [Abstract][Full Text] [Related]
7. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines. Tomonari K J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209 [TBL] [Abstract][Full Text] [Related]
8. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related]
9. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1. Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271 [TBL] [Abstract][Full Text] [Related]
10. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems. Azuma H; Phillips JD; Green WR J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116 [TBL] [Abstract][Full Text] [Related]
11. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells. Hardt C; Diamantstein T; Wagner H Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of cyclosporin A on cloned T cells. Herold KC; Lancki DW; Moldwin RL; Fitch FW J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576 [TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
14. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes. Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105 [TBL] [Abstract][Full Text] [Related]
15. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes. Takai Y; Herrmann SH; Greenstein JL; Spitalny GL; Burakoff SJ J Immunol; 1986 Dec; 137(11):3494-500. PubMed ID: 3097123 [TBL] [Abstract][Full Text] [Related]
16. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156 [TBL] [Abstract][Full Text] [Related]
17. Derivation of cytotoxic T cell lines that express T cell receptor but exhibit reversible loss of stable antigen binding. Gnarra JR; Engelhard VH J Immunol; 1986 Nov; 137(10):3057-64. PubMed ID: 3490508 [TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines. Orosz CG; Zinn NE; Olsen RG; Mathes LE J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289 [TBL] [Abstract][Full Text] [Related]
19. Immunoregulation by mouse T-cell clones. I. Suppression and amplification of cytotoxic responses by cloned H-Y-specific cytolytic T lymphocytes. Simon MM; Moll H; Prester M; Nerz G; Eichmann K Cell Immunol; 1984 Jun; 86(1):206-21. PubMed ID: 6202426 [TBL] [Abstract][Full Text] [Related]
20. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines. Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]